Kala Pharmaceuticals, Inc. Purchase Agreements
5 Contracts & Agreements
- Securities Purchase Agreement, dated June 26, 2024, by and among KALA BIO, Inc. and the purchasers party thereto (Filed With SEC on June 27, 2024)
- Securities Purchase Agreement, dated March 25, 2024, by and among KALA BIO, Inc. and the purchasers party thereto (Filed With SEC on March 26, 2024)
- Securities Purchase Agreement, dated December 21, 2023, by and among KALA BIO, Inc. and the purchasers party thereto (Filed With SEC on December 22, 2023)
- Securities Purchase Agreement, dated November 28, 2022, by and among Kala Pharmaceuticals, Inc. and the purchasers party thereto (Filed With SEC on November 28, 2022)
- Asset Purchase Agreement, by and between Kala Pharmaceuticals, Inc., Alcon Pharmaceuticals Ltd. and Alcon Vision, LLC (Filed With SEC on May 23, 2022)
